Article

The Benefits of Personal Training

Author(s):

Exercise and nutrition intervention for patients with cancer could help with symptoms from treatment.

As director of Rocky Mountain Cancer Rehabilitation Institute at the University of Northern Colorado in Greeley, Colo., part of Reid Hayward’s mission is to investigate exercise and nutrition as an intervention for symptoms related to cancer treatment.

Hayward and his students offer one-on-one coaching three days a week at the cancer center, he says. Think of them as cancer personal trainers. “Once we get the patients in here,” Hayward continues, “they’re hooked.”

“Other centers give them a handout. We give them an initial assessment of balance, strength and endurance, and then reassess every three months.”

He witnesses the benefits of working out during and after treatment, but he’s not surprised that patients aren’t lining up at the door before treatment starts. Most “are overwhelmed by too many other things with a higher priority.”

So, when he doesn’t have enough trial participants, he and his team work with rats to study aerobic conditioning and the effects of chemotherapy.

It’s difficult to apply lessons learned in animal trials directly to humans, although many physicians recommend light exercise to reduce certain treatment-related effects, such as fatigue and depression. Hayward is convinced that “the protective effect of exercise” can have a lasting impact. He suggests—only half-kiddingly—that patients receiving chemotherapy might be well served to “jog to treatment.”

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Imiage of two doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Related Content